<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37528111</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The plasma metabolome of long COVID patients two years after infection.</ArticleTitle><Pagination><StartPage>12420</StartPage><MedlinePgn>12420</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12420</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-39049-x</ELocationID><Abstract><AbstractText>One of the major challenges currently faced by global health systems is the prolonged COVID-19 syndrome (also known as "long COVID") which has emerged as a consequence of the SARS-CoV-2 epidemic. It is estimated that at least 30% of patients who have had COVID-19 will develop long COVID. In this study, our goal was to assess the plasma metabolome in a total of 100 samples collected from healthy controls, COVID-19 patients, and long COVID patients recruited in Mexico between 2020 and 2022. A targeted metabolomics approach using a combination of LC-MS/MS and FIA MS/MS was performed to quantify 108 metabolites. IL-17 and leptin were measured in long COVID patients by immunoenzymatic assay. The comparison of paired COVID-19/long COVID-19 samples revealed 53 metabolites that were statistically different. Compared to controls, 27 metabolites remained dysregulated even after two years. Post-COVID-19 patients displayed a heterogeneous metabolic profile. Lactic acid, lactate/pyruvate ratio, ornithine/citrulline ratio, and arginine were identified as the most relevant metabolites for distinguishing patients with more complicated long COVID evolution. Additionally, IL-17 levels were significantly increased in these patients. Mitochondrial dysfunction, redox state imbalance, impaired energy metabolism, and chronic immune dysregulation are likely to be the main hallmarks of long COVID even two years after acute COVID-19 infection.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L&#xf3;pez-Hern&#xe1;ndez</LastName><ForeName>Yamil&#xe9;</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CONAHCyT-Metabolomics and Proteomics Laboratory, Academic Unit of Biological Sciences, Autonomous University of Zacatecas, 98000, Zacatecas, Mexico. ylopezher@conacyt.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mon&#xe1;rrez-Espino</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Research, Christus Muguerza del Parque Hospital - University of Monterrey, 31125, Chihuahua, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>David Alejandro Garc&#xed;a</ForeName><Initials>DAG</Initials><AffiliationInfo><Affiliation>Academic Unit of Biological Sciences, Autonomous University of Zacatecas, 98000, Zacatecas, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Jiamin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Metabolomics Innovation Centre, University of Alberta, Edmonton, AB, T6G 1C9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borrego</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Departamento de Epidemiolog&#xed;a, Hospital General de Zona #1 "Emilio Varela Luj&#xe1;n", Instituto Mexicano del Seguro Social, Zacatecas, 98000, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Calzada</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alberta, Edmonton, AB, T6G 1C9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elizalde-D&#xed;az</LastName><ForeName>Jos&#xe9; Pedro</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Laboratory of Cell Communication &amp; Extracellular Vesicles, Division of Basic Science, Instituto Nacional de Medicina Gen&#xf3;mica, 14610, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandal</LastName><ForeName>Rupasri</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Metabolomics Innovation Centre, University of Alberta, Edmonton, AB, T6G 1C9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berjanskii</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Metabolomics Innovation Centre, University of Alberta, Edmonton, AB, T6G 1C9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Mart&#xed;nez</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Cell Communication &amp; Extracellular Vesicles, Division of Basic Science, Instituto Nacional de Medicina Gen&#xf3;mica, 14610, Ciudad de M&#xe9;xico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Jes&#xfa;s Adri&#xe1;n</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>MicroRNAs and Cancer Laboratory, Academic Unit of Biological Sciences, Autonomous University of Zacatecas, 98000, Zacatecas, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wishart</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>The Metabolomics Innovation Centre, University of Alberta, Edmonton, AB, T6G 1C9, Canada. dwishart@ualberta.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Alberta, Edmonton, AB, T6G 1C9, Canada. dwishart@ualberta.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FS 148461</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020381">Interleukin-17</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020381" MajorTopicYN="Y">Interleukin-17</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055442" MajorTopicYN="N">Metabolome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>1</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37528111</ArticleId><ArticleId IdType="pmc">PMC10394026</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-39049-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-39049-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lam W, Zhong N, Tan W. Overview on SARS in Asia and the World. Respirology. 2003;8:S2&#x2013;S5. doi: 10.1046/j.1440-1843.2003.00516.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1440-1843.2003.00516.x</ArticleId><ArticleId IdType="pmc">PMC7159403</ArticleId><ArticleId IdType="pubmed">15018125</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Mutair A, Ambani Z. Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: Updates and implications for practice. J. Int. Med. Res. 2020;48:030006051985803. doi: 10.1177/0300060519858030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060519858030</ArticleId><ArticleId IdType="pmc">PMC7140187</ArticleId><ArticleId IdType="pubmed">31256729</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023 doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace PG. Epidemiology: A critical review. Br. Med. Bull. 1991;47:942&#x2013;951. doi: 10.1093/oxfordjournals.bmb.a072522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.bmb.a072522</ArticleId><ArticleId IdType="pubmed">1794092</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. BMJ. 2006;333:575. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kukla M, et al. COVID-19, MERS and SARS with concomitant liver injury&#x2014;systematic review of the existing literature. J. Clin. Med. 2020;9:1420. doi: 10.3390/jcm9051420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9051420</ArticleId><ArticleId IdType="pmc">PMC7290752</ArticleId><ArticleId IdType="pubmed">32403255</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir. Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlemmer F, et al. Respiratory recovery trajectories after severe-to-critical COVID-19: A 1-year prospective multicentre study. Eur. Respir. J. 2023;61:2201532. doi: 10.1183/13993003.01532-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01532-2022</ArticleId><ArticleId IdType="pmc">PMC10066566</ArticleId><ArticleId IdType="pubmed">36669777</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintos-Pascual I, et al. Is SARS-CoV-2 the only cause of long-COVID? AIDS Rev. 2022;24:25. doi: 10.24875/AIDSRev.22000025.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/AIDSRev.22000025</ArticleId><ArticleId IdType="pubmed">36427058</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Van Oostdam AS, et al. Immunometabolic signatures predict risk of progression to sepsis in COVID-19. PLoS ONE. 2021;16:e0256784. doi: 10.1371/journal.pone.0256784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256784</ArticleId><ArticleId IdType="pmc">PMC8405033</ArticleId><ArticleId IdType="pubmed">34460840</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R, et al. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine. 2023;56:101783. doi: 10.1016/j.eclinm.2022.101783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101783</ArticleId><ArticleId IdType="pmc">PMC9830133</ArticleId><ArticleId IdType="pubmed">36643619</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav. Immun. Health. 2020;9:100163. doi: 10.1016/j.bbih.2020.100163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100163</ArticleId><ArticleId IdType="pmc">PMC7581383</ArticleId><ArticleId IdType="pubmed">33111132</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat. Metab. 2021;3:774&#x2013;785. doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Negahdaripour M. Post-COVID-19 hyperglycemia: A concern in selection of therapeutic regimens. Iran J. Med. Sci. 2021;46:235&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8288489</ArticleId><ArticleId IdType="pubmed">34305235</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, et al. Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection. Braz. J. Psychiatry. 2023 doi: 10.47626/1516-4446-2022-3002.</Citation><ArticleIdList><ArticleId IdType="doi">10.47626/1516-4446-2022-3002</ArticleId><ArticleId IdType="pmc">PMC10288478</ArticleId><ArticleId IdType="pubmed">36917827</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Ruppert D, Levine SM, Hanson MR. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol. Biosyst. 2017;13:371&#x2013;379. doi: 10.1039/C6MB00600K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6MB00600K</ArticleId><ArticleId IdType="pmc">PMC5365380</ArticleId><ArticleId IdType="pubmed">28059425</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, et al. Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: Implications for assessment of post-acute COVID-19 syndrome. J. Proteome Res. 2021;20:3315&#x2013;3329. doi: 10.1021/acs.jproteome.1c00224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticinesi A, Guerra A, Nouvenne A, Meschi T, Maggi S. Disentangling the complexity of nutrition, frailty and gut microbial pathways during aging: A focus on hippuric acid. Nutrients. 2023;15:1138. doi: 10.3390/nu15051138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15051138</ArticleId><ArticleId IdType="pmc">PMC10005077</ArticleId><ArticleId IdType="pubmed">36904138</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G, et al. Proline and hydroxyproline metabolism: Implications for animal and human nutrition. Amino Acids. 2011;40:1053&#x2013;1063. doi: 10.1007/s00726-010-0715-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-010-0715-z</ArticleId><ArticleId IdType="pmc">PMC3773366</ArticleId><ArticleId IdType="pubmed">20697752</ArticleId></ArticleIdList></Reference><Reference><Citation>Phang JM. The regulatory mechanisms of proline and hydroxyproline metabolism: Recent advances in perspective. Front. Oncol. 2023;12:1118675. doi: 10.3389/fonc.2022.1118675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2022.1118675</ArticleId><ArticleId IdType="pmc">PMC9930595</ArticleId><ArticleId IdType="pubmed">36818667</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar Srivastava A, Khare P, Kumar Nagar H, Raghuwanshi N, Srivastava R. Hydroxyproline: A potential biochemical marker and its role in the pathogenesis of different diseases. Curr. Protein Pept. Sci. 2016;17:596&#x2013;602. doi: 10.2174/1389203717666151201192247.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203717666151201192247</ArticleId><ArticleId IdType="pubmed">26916157</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange, S. M. &amp; Parekh, M. Collagen Vascular Disease Associated with Interstitial Lung (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">32644520</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020;182:59&#x2013;72.e15. doi: 10.1016/j.cell.2020.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, et al. The trans-omics landscape of COVID-19. Nat. Commun. 2021;12:4543. doi: 10.1038/s41467-021-24482-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24482-1</ArticleId><ArticleId IdType="pmc">PMC8316550</ArticleId><ArticleId IdType="pubmed">34315889</ArticleId></ArticleIdList></Reference><Reference><Citation>Atila A, et al. The serum amino acid profile in COVID-19. Amino Acids. 2021;53:1569&#x2013;1588. doi: 10.1007/s00726-021-03081-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-021-03081-w</ArticleId><ArticleId IdType="pmc">PMC8487804</ArticleId><ArticleId IdType="pubmed">34605988</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoodi M, et al. Disturbed lipid and amino acid metabolisms in COVID-19 patients. J. Mol. Med. 2022;100:555&#x2013;568. doi: 10.1007/s00109-022-02177-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-022-02177-4</ArticleId><ArticleId IdType="pmc">PMC8783191</ArticleId><ArticleId IdType="pubmed">35064792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansone L, et al. Amino acid metabolism is significantly altered at the time of admission in hospital for severe COVID-19 patients: Findings from longitudinal targeted metabolomics analysis. Microbiol. Spectr. 2021;9:e0033821. doi: 10.1128/spectrum.00338-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00338-21</ArticleId><ArticleId IdType="pmc">PMC8653833</ArticleId><ArticleId IdType="pubmed">34878333</ArticleId></ArticleIdList></Reference><Reference><Citation>Do&#x11f;an HO, et al. Understanding the pathophysiological changes via untargeted metabolomics in COVID-19 patients. J. Med. Virol. 2021;93:2340&#x2013;2349. doi: 10.1002/jmv.26716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26716</ArticleId><ArticleId IdType="pubmed">33300133</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, et al. High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial. Nutr. Metab. Cardiovasc. Dis. 2019;29:1040&#x2013;1049. doi: 10.1016/j.numecd.2019.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2019.06.005</ArticleId><ArticleId IdType="pmc">PMC9257877</ArticleId><ArticleId IdType="pubmed">31377179</ArticleId></ArticleIdList></Reference><Reference><Citation>Newgard CB, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311&#x2013;326. doi: 10.1016/j.cmet.2009.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2009.02.002</ArticleId><ArticleId IdType="pmc">PMC3640280</ArticleId><ArticleId IdType="pubmed">19356713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayd&#x131;n H, et al. Glutamine-driven metabolic adaptation to COVID-19 infection. Indian J. Clin. Biochem. 2023;38:83&#x2013;93. doi: 10.1007/s12291-022-01037-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12291-022-01037-9</ArticleId><ArticleId IdType="pmc">PMC8992789</ArticleId><ArticleId IdType="pubmed">35431470</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesilkaya UH, Sen M, Balcioglu YH. COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway. J. Clin. Neurosci. 2021;87:153&#x2013;155. doi: 10.1016/j.jocn.2021.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2021.03.007</ArticleId><ArticleId IdType="pmc">PMC7955917</ArticleId><ArticleId IdType="pubmed">33863524</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeira C, et al. Blood levels of glutamate and glutamine in recent onset and chronic schizophrenia. Front. Psychiatry. 2018;9:713. doi: 10.3389/fpsyt.2018.00713.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00713</ArticleId><ArticleId IdType="pmc">PMC6305751</ArticleId><ArticleId IdType="pubmed">30618883</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldana BI, et al. Glutamate-glutamine homeostasis is perturbed in neurons and astrocytes derived from patient iPSC models of frontotemporal dementia. Mol. Brain. 2020;13:125. doi: 10.1186/s13041-020-00658-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-00658-6</ArticleId><ArticleId IdType="pmc">PMC7491073</ArticleId><ArticleId IdType="pubmed">32928252</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel KM, Schiller J, Galuska CE, Fuchs B. Phospholipases and reactive oxygen species derived lipid biomarkers in healthy and diseased humans and animals: A focus on lysophosphatidylcholine. Front. Physiol. 2021;12:732319. doi: 10.3389/fphys.2021.732319.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.732319</ArticleId><ArticleId IdType="pmc">PMC8631503</ArticleId><ArticleId IdType="pubmed">34858200</ArticleId></ArticleIdList></Reference><Reference><Citation>Drobnik W, et al. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J. Lipid Res. 2003;44:754&#x2013;761. doi: 10.1194/jlr.M200401-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M200401-JLR200</ArticleId><ArticleId IdType="pubmed">12562829</ArticleId></ArticleIdList></Reference><Reference><Citation>Che X, et al. Metabolomic evidence for peroxisomal dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. Int. J. Mol. Sci. 2022;23:7906. doi: 10.3390/ijms23147906.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23147906</ArticleId><ArticleId IdType="pmc">PMC9320121</ArticleId><ArticleId IdType="pubmed">35887252</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Risks and burdens of incident dyslipidaemia in long COVID: A cohort study. Lancet Diabetes Endocrinol. 2023;11:120&#x2013;128. doi: 10.1016/S2213-8587(22)00355-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00355-2</ArticleId><ArticleId IdType="pmc">PMC9873268</ArticleId><ArticleId IdType="pubmed">36623520</ArticleId></ArticleIdList></Reference><Reference><Citation>Alb&#xf3;niga OE, et al. Metabolic snapshot of plasma samples reveals new pathways implicated in SARS-CoV-2 pathogenesis. J. Proteome Res. 2022;21:623&#x2013;634. doi: 10.1021/acs.jproteome.1c00786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00786</ArticleId><ArticleId IdType="pubmed">35133846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HS. Do an altered gut microbiota and an associated leaky gut affect COVID-19 severity? mBio. 2021;12:e03022. doi: 10.1128/mBio.03022-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03022-20</ArticleId><ArticleId IdType="pmc">PMC7845625</ArticleId><ArticleId IdType="pubmed">33436436</ArticleId></ArticleIdList></Reference><Reference><Citation>Firpo MR, et al. Targeting polyamines inhibits coronavirus infection by reducing cellular attachment and entry. ACS Infect. Dis. 2021;7:1423&#x2013;1432. doi: 10.1021/acsinfecdis.0c00491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00491</ArticleId><ArticleId IdType="pmc">PMC7539557</ArticleId><ArticleId IdType="pubmed">32966040</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese JT, et al. Generalisable long COVID subtypes: Findings from the NIH N3C and RECOVER programmes. EBioMedicine. 2023;87:104413. doi: 10.1016/j.ebiom.2022.104413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104413</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023 doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, et al. Plasma metabolomic profiling of patients recovered from coronavirus disease 2019 (COVID-19) with pulmonary sequelae 3 months after discharge. Clin. Infect. Dis. 2021;73:2228&#x2013;2239. doi: 10.1093/cid/ciab147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab147</ArticleId><ArticleId IdType="pmc">PMC7929060</ArticleId><ArticleId IdType="pubmed">33596592</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A, et al. Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome. Sci. Rep. 2019;9:18817. doi: 10.1038/s41598-019-55473-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-55473-4</ArticleId><ArticleId IdType="pmc">PMC6906377</ArticleId><ArticleId IdType="pubmed">31827223</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G, et al. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic. Biol. Med. 2005;39:584&#x2013;589. doi: 10.1016/j.freeradbiomed.2005.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.04.020</ArticleId><ArticleId IdType="pubmed">16085177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane RJM, et al. Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome. J. Neurol. Neurosurg. Psychiatry. 1998;64:362&#x2013;367. doi: 10.1136/jnnp.64.3.362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.64.3.362</ArticleId><ArticleId IdType="pmc">PMC2169994</ArticleId><ArticleId IdType="pubmed">9527150</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane RJM, Barrett MC, Taylor DJ, Kemp GJ, Lodi R. Heterogeneity in chronic fatigue syndrome: Evidence from magnetic resonance spectroscopy of muscle. Neuromuscul. Disord. 1998;8:204&#x2013;209. doi: 10.1016/S0960-8966(98)00021-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-8966(98)00021-2</ArticleId><ArticleId IdType="pubmed">9631403</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovi&#x107; V, et al. Antioxidative defence alterations in skeletal muscle during prolonged acclimation to cold: Role of l-arginine/NO-producing pathway. J. Exp. Biol. 2008;211:114&#x2013;120. doi: 10.1242/jeb.012674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jeb.012674</ArticleId><ArticleId IdType="pubmed">18083739</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E, et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am. J. Respir. Crit. Care Med. 2022;205:126&#x2013;129. doi: 10.1164/rccm.202108-1903LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202108-1903LE</ArticleId><ArticleId IdType="pmc">PMC8865580</ArticleId><ArticleId IdType="pubmed">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>Debray F-G, et al. Diagnostic accuracy of blood lactate-to-pyruvate molar ratio in the differential diagnosis of congenital lactic acidosis. Clin. Chem. 2007;53:916&#x2013;921. doi: 10.1373/clinchem.2006.081166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2006.081166</ArticleId><ArticleId IdType="pubmed">17384007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano E, et al. Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Sci. Rep. 2016;6:34990. doi: 10.1038/srep34990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34990</ArticleId><ArticleId IdType="pmc">PMC5057083</ArticleId><ArticleId IdType="pubmed">27725700</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker V. Severe hyperammonaemia in adults not explained by liver disease. Ann. Clin. Biochem. 2012;49:214&#x2013;228. doi: 10.1258/acb.2011.011206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/acb.2011.011206</ArticleId><ArticleId IdType="pubmed">22349554</ArticleId></ArticleIdList></Reference><Reference><Citation>Saligan LN, Lukkahatai N, Jin Zhang Z, Cheung CW, Min Wang X. Altered Cd8+ T lymphocyte response triggered by arginase 1: Implication for fatigue intensification during localized radiation therapy in prostate cancer patients. Neuropsychiatry. 2018;08:100454. doi: 10.4172/Neuropsychiatry.1000454.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/Neuropsychiatry.1000454</ArticleId><ArticleId IdType="pmc">PMC6198670</ArticleId><ArticleId IdType="pubmed">30364895</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, et al. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26. doi: 10.1186/s12916-021-02228-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuber-Champier A, et al. Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phase. Brain Behav. Immun. Health. 2022;26:100511. doi: 10.1016/j.bbih.2022.100511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100511</ArticleId><ArticleId IdType="pmc">PMC9477785</ArticleId><ArticleId IdType="pubmed">36128057</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeachy MJ, Cua DJ, Gaffen SL. The IL-17 family of cytokines in health and disease. Immunity. 2019;50:892&#x2013;906. doi: 10.1016/j.immuni.2019.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.03.021</ArticleId><ArticleId IdType="pmc">PMC6474359</ArticleId><ArticleId IdType="pubmed">30995505</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmendia JV, Garc&#xed;a AH, De Sanctis CV, Hajd&#xfa;ch M, De Sanctis JB. Autoimmunity and immunodeficiency in severe SARS-CoV-2 infection and prolonged COVID-19. Curr. Issues Mol. Biol. 2022;45:33&#x2013;50. doi: 10.3390/cimb45010003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb45010003</ArticleId><ArticleId IdType="pmc">PMC9857622</ArticleId><ArticleId IdType="pubmed">36661489</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou F, et al. Excessive polyamine generation in keratinocytes promotes self-RNA sensing by dendritic cells in psoriasis. Immunity. 2020;53:204&#x2013;216.e10. doi: 10.1016/j.immuni.2020.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.004</ArticleId><ArticleId IdType="pubmed">32553276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazdyrev E, et al. Lung fibrosis after COVID-19: Treatment prospects. Pharmaceuticals. 2021;14:807. doi: 10.3390/ph14080807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14080807</ArticleId><ArticleId IdType="pmc">PMC8398080</ArticleId><ArticleId IdType="pubmed">34451904</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini L, et al. Post-COVID-19 immune-mediated neurological complications in children: An ambispective study. Pediatr. Neurol. 2022;136:20&#x2013;27. doi: 10.1016/j.pediatrneurol.2022.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2022.06.010</ArticleId><ArticleId IdType="pmc">PMC9258417</ArticleId><ArticleId IdType="pubmed">36049379</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc. Natl. Acad. Sci. USA. 2017;114:E7150&#x2013;E7158. doi: 10.1073/pnas.1710519114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710519114</ArticleId><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Procaccini C, Pucino V, Mantzoros CS, Matarese G. Leptin in autoimmune diseases. Metabolism. 2015;64:92&#x2013;104. doi: 10.1016/j.metabol.2014.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2014.10.014</ArticleId><ArticleId IdType="pubmed">25467840</ArticleId></ArticleIdList></Reference><Reference><Citation>Stringer EA, et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: Evidence of inflammatory pathology. J. Transl. Med. 2013;11:93. doi: 10.1186/1479-5876-11-93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-11-93</ArticleId><ArticleId IdType="pmc">PMC3637529</ArticleId><ArticleId IdType="pubmed">23570606</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M, et al. Effects of l-arginine plus vitamin C supplementation on physical performance, endothelial function, and persistent fatigue in adults with long COVID: A single-blind randomized controlled trial. Nutrients. 2022;14:4984. doi: 10.3390/nu14234984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14234984</ArticleId><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby T. COVID-19 survivor experiencing long-term symptoms. Lancet Respir. Med. 2021;9:570&#x2013;572. doi: 10.1016/S2213-2600(21)00092-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00092-8</ArticleId><ArticleId IdType="pmc">PMC7906738</ArticleId><ArticleId IdType="pubmed">33587889</ArticleId></ArticleIdList></Reference><Reference><Citation>Gir&#xf3;n P&#xe9;rez DA, et al. Post-COVID-19 syndrome in outpatients and its association with viral load. Int. J. Environ. Res. Public Health. 2022;19:15145. doi: 10.3390/ijerph192215145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192215145</ArticleId><ArticleId IdType="pmc">PMC9690223</ArticleId><ArticleId IdType="pubmed">36429864</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, et al. Coding long COVID: Characterizing a new disease through an ICD-10 lens. BMC Med. 2023;21:58. doi: 10.1186/s12916-023-02737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02737-6</ArticleId><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. The Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y, et al. Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19. Sci. Rep. 2021;11:14732. doi: 10.1038/s41598-021-94171-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94171-y</ArticleId><ArticleId IdType="pmc">PMC8290000</ArticleId><ArticleId IdType="pubmed">34282210</ArticleId></ArticleIdList></Reference><Reference><Citation>Shear MK, et al. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A) Depress Anxiety. 2001;13:166&#x2013;178. doi: 10.1002/da.1033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/da.1033</ArticleId><ArticleId IdType="pubmed">11413563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56&#x2013;62. doi: 10.1136/jnnp.23.1.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.23.1.56</ArticleId><ArticleId IdType="pmc">PMC495331</ArticleId><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580&#x2013;586. doi: 10.1378/chest.93.3.580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.93.3.580</ArticleId><ArticleId IdType="pubmed">3342669</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: A web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009;37:W652&#x2013;W660. doi: 10.1093/nar/gkp356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp356</ArticleId><ArticleId IdType="pmc">PMC2703878</ArticleId><ArticleId IdType="pubmed">19429898</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>